Cynata Therapeutics Ltd
ASX:CYP
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Cynata Therapeutics Ltd
ASX:CYP
|
AU |
|
Goldlion Holdings Ltd
F:GLH
|
HK |
Shareholder Yield
Current shareholder yield for CYP is
.
Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?
Peers Comparison
Shareholder Yield
Price Appreciation
CYP Price
Cynata Therapeutics Ltd
| Average Annual Return | -3.11% |
| Standard Deviation of Annual Returns | 73% |
| Max Drawdown | -83% |
| Market Capitalization | 70m AUD |
| Shares Outstanding | 237 450 000 |
| Percentage of Shares Shorted |
N/A
|
CYP Return Decomposition
Main factors of price return
Stock Splits
CYP's latest stock split occurred on Dec 15, 2020
The company executed a 336-for-335 stock split, meaning that for every 335 shares held, investors received 336 new shares.
Before the split, CYP traded at 0.7328 per share. Afterward, the share price was about 0.71.
The adjusted shares began trading on Dec 15, 2020. This was CYP's 4th stock split, following the previous one in Oct 31, 2013.
